MedPlus subsidiary faces drug license suspension, revenue hit expected

MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, received a 21-day suspension order for a drug license. The suspension pertains to a store located in Shanti Nagar, Nagpur, Maharashtra.

The order was issued by the assistant commissioner & licensing authority, Food & Drug Administration, MH, Nagpur, Maharashtra, and was received on November 1, 2025. This action falls under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945.

MedPlus anticipates a potential revenue loss of approximately Rs 4.34 lacs due to this suspension. The company made this disclosure in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.